Novel lactic acid bacteria having immunoregulatory activities derived from human digestive tract and use thereof

摘要

According to the present invention, a specific lactobacillus strain, a specific bifidobacterium strain, a specific streptococcus strain, or a specific collinsella strain is separated from human excrement to have high stability, and have various biological activities such as an immune regulatory effect, an immune enhancement effect, an antiallergy effect, an antiinflammation effect, a colitis improvement effect, an arthritis improvement effect, an anti-obesity effect, an anti-stress effect, an anti-anxiety effect, an anti-depression effect, or an anti-schizophrenia effect. According to the present invention, the specific lactobacillus strain, the specific bifidobacterium strain, the specific streptococcus strain, or the specific collinsella strain is able to be used as a material for regulating immunity, enhancing immunity, suppressing an inflammation reaction, and relieving stress, and also, is able to be used as a functional food and drug material for preventing, improving, or treating allergy, inflammation, colitis, arthritis, obesity, anxiety, depression, or schizophrenia.